Goodrx Holdings Inc
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products … Read more
Goodrx Holdings Inc (GDRX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.127x
Based on the latest financial reports, Goodrx Holdings Inc (GDRX) has a cash flow conversion efficiency ratio of 0.127x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($76.02 Million) by net assets ($600.71 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Goodrx Holdings Inc - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Goodrx Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Goodrx Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Goodrx Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hawthorn Bancshares Inc
NASDAQ:HWBK
|
0.087x |
|
Napatech A/S
OL:NAPA
|
-0.214x |
|
XOMA CORP.PRF.SH.SER.A 25
F:X0M
|
N/A |
|
MAS Financial Services Limited
NSE:MASFIN
|
-0.351x |
|
Qingdao Victall Railway Co Ltd
SHG:605001
|
-0.076x |
|
Suzhou Wanxiang Technology Co. Ltd.
SHE:301180
|
-0.059x |
|
InfoVision Optoelectronics Kunshan Co Ltd
SHG:688055
|
-0.009x |
|
CPH Group AG
F:1L6
|
N/A |
Annual Cash Flow Conversion Efficiency for Goodrx Holdings Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Goodrx Holdings Inc from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $724.66 Million | $183.89 Million | 0.254x | +39.82% |
| 2023-12-31 | $761.96 Million | $138.29 Million | 0.181x | +0.75% |
| 2022-12-31 | $814.83 Million | $146.78 Million | 0.180x | -16.20% |
| 2021-12-31 | $831.68 Million | $178.78 Million | 0.215x | +16.43% |
| 2020-12-31 | $711.36 Million | $131.34 Million | 0.185x | +341.10% |
| 2019-12-31 | $-1.09 Billion | $83.29 Million | -0.077x | -96.71% |
| 2018-12-31 | $-1.16 Billion | $45.25 Million | -0.039x | -- |